Corticotropin-releasing factor receptors in GtoPdb v.2023.1

Authors

  • Frank M. Dautzenberg Johnson & Johnson Pharmaceutical Research & Development
  • Dimitri E. Grigoriadis Neurocrine Biosciences
  • Richard L. Hauger University of California San Diego
  • Victoria B. Risbrough University of California San Diego
  • Thomas Steckler Johnson & Johnson Pharmaceutical Research & Development
  • Wylie W. Vale Salk Institute
  • Rita J. Valentino Children's Hospital of Philadelphia

DOI:

https://doi.org/10.2218/gtopdb/F19/2023.1

Abstract

Corticotropin-releasing factor (CRF, nomenclature as agreed by the NC-IUPHAR subcommittee on Corticotropin-releasing Factor Receptors [34]) receptors are activated by the endogenous peptides corticotrophin-releasing hormone, a 41 amino-acid peptide, urocortin 1, 40 amino-acids, urocortin 2, 38 amino-acids and urocortin 3, 38 amino-acids. CRF1 and CRF2 receptors are activated non-selectively by CRH and UCN. CRF2 receptors are selectively activated by UCN2 and UCN3. Binding to CRF receptors can be conducted using radioligands [125I]Tyr0-CRF or [125I]Tyr0-sauvagine with Kd values of 0.1-0.4 nM. CRF1 and CRF2 receptors are non-selectively antagonized by α-helical CRF, D-Phe-CRF-(12-41) and astressin. CRF1 receptors are selectively antagonized by small molecules NBI27914, R121919, antalarmin, CP 154,526, CP 376,395. CRF2 receptors are selectively antagonized by antisauvagine and astressin 2B.

Downloads

Download data is not yet available.

Published

26-Apr-2023

Issue

Section

Summaries

How to Cite

“Corticotropin-releasing factor receptors in GtoPdb v.2023.1” (2023) IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). doi:10.2218/gtopdb/F19/2023.1.